Pharmaceutical firm Moderna has released another tranche of data relating to the effectiveness of its COVID-19 vaccine, with introduction of the jab expected in the UK and US before the end of the year. Final analysis of data from a trial involving 30,000 participants showed the vaccine was more than 94% effective in preventing COVID-19 and 100% effective in preventing severe coronavirus.
The Daily Telegraph Financial Times



Comments are closed